Inpatients of Mycoplasma pneumoniae, 350% increase compared to last year, risk of severe pneumonia if treatment is delayed

Oct 18, 2024

Inpatients of Mycoplasma pneumoniae, 350% increase compared to last year, risk of severe pneumonia if treatment is delayed
Mycoplasma pneumoniae appears to be very popular this year, so caution is needed.

According to data from the Korea Centers for Disease Control and Prevention, the number of patients hospitalized with Mycoplasma pneumoniae in 2024 was 26, which is a significant increase of 350% (4,373 hospitalized patients) compared to last year. Compared to the number of inpatients (1591 people) in 2022, the number is over 1,161% (12.6 times).

In particular, the number of patients is increasing rapidly as it has become cold recently. 96 patients were hospitalized for mycoplasma pneumonia in the spring of the 13th week (3.25~3.31) of 2024, the lowest number this year. In contrast, in the last 41 weeks (10.7-10.13), the number of inpatients has increased more than 10 times to 1,001.



As of the 41st week, 7-12 years old was the most common with 341 inpatients by age. Next, ▲ 274 people aged 1 to 6 years old ▲ 170 people aged 13 to 18 years old ▲ 153 people aged 16 to 49 years ▲ 37 people aged 65 or older ▲ 19 people aged 50 to 64 years ▲ 7 people aged 0 years old.

When infected with mycoplasma, symptoms such as coughing and breathing sounds (thousand people), fever, and sore throat appear. It is similar to cold symptoms in the early stages, but cough and fever tend to worsen.



Mycoplasma bacteria are the main cause of pneumonia, and 10 to 15% of them can develop severe pneumonia, so early treatment is important.

In particular, even if children are suffering from mycoplasma infection, they are at high risk of developing simultaneous infection with other viruses, so parents need preventive measures and early treatment, such as hygiene management and reducing contact with infected people.



Professor Hyung-koo Kang of the Department of Respiratory Medicine at Inje University Ilsan Paik Hospital, "Micplasma pneumoniae uses macrolide or respiratory quinolone antibiotics"Usually, antibiotics alone can treat it relatively well, but if treatment is delayed and severe pneumonia occurs, it may be a situation that requires intensive treatment, so caution is needed."

Professor Kang Hyung-gu also said, "Macoplasma infection can cause pneumonia or worsen lung disease"Respiratory patients with asthma or chronic obstructive pulmonary disease, long-term smokers, chronic renal failure, myocardial infarction, immunocompromised cancer patients, and children need early treatment, especially to prevent them from falling into pneumonia."



Inpatients of Mycoplasma pneumoniae, 350% increase compared to last year, risk of severe pneumonia if treatment is delayed
Professor Kang Hyung-gu in treatment


bellho@sportschosun.com